For instance, two clinical trials found that the LOF mutation of ANGPTL4 gene was closely associated with decreased serum TG levels and increased HDL-C levels [102], whereas another study demonstrated ANGPTL4 could not significantly modulated the serum TG concentrations in patients with hypothyroidism [88]. Here, ANGPTL4 is linked to hypothyroidism.